232 related articles for article (PubMed ID: 32008558)
1. MRI Combined with Magnetic Resonance Cholangiopancreatography for Diagnosis of Benign and Malignant Pancreatic Intraductal Papillary Mucinous Neoplasms.
Liu X; Xu W; Liu Z; Ye J
Curr Med Imaging Rev; 2019; 15(5):504-510. PubMed ID: 32008558
[TBL] [Abstract][Full Text] [Related]
2. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of enhanced magnetic resonance imaging and magnetic resonance cholangiopancreatography in the differential diagnosis of benign and malignant intraductal papillary mucinous neoplasms of the pancreas].
Qian HF; Li FQ; Hu CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Feb; 36(1):98-101. PubMed ID: 24581137
[TBL] [Abstract][Full Text] [Related]
5. Abbreviated Magnetic Resonance Imaging With Breath-Hold Three-Dimensional Magnetic Resonance Cholangiopancreatography: Assessment of Malignant Risk of Pancreatic Intraductal Papillary Mucinous Neoplasm.
Yoo J; Min JH; Lee DH; Hur BY; Kim SW; Kim E
J Magn Reson Imaging; 2021 Oct; 54(4):1177-1186. PubMed ID: 33779024
[TBL] [Abstract][Full Text] [Related]
6. Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines.
Lee JE; Choi SY; Min JH; Yi BH; Lee MH; Kim SS; Hwang JA; Kim JH
Radiology; 2019 Oct; 293(1):134-143. PubMed ID: 31478800
[TBL] [Abstract][Full Text] [Related]
7. Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI.
Min JH; Kim YK; Kim SK; Kim H; Ahn S
Eur Radiol; 2021 Jul; 31(7):4774-4784. PubMed ID: 33409798
[TBL] [Abstract][Full Text] [Related]
8. Intraductal papillary mucinous neoplasms of the pancreas: evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography.
Kim SH; Lee JM; Lee ES; Baek JH; Kim JH; Han JK; Choi BI
Radiology; 2015 Mar; 274(3):723-33. PubMed ID: 25302831
[TBL] [Abstract][Full Text] [Related]
9. MRI findings of intraductal papillary mucinous neoplasms (IPMNs).
Lana S; Vallara M; Bono NE; Russo G; Artioli G; Capretti G; Paladini I; Pesce A; Ruggirello M; Barbalace S; Mostardi M
Acta Biomed; 2016 Jul; 87 Suppl 3():28-33. PubMed ID: 27467864
[TBL] [Abstract][Full Text] [Related]
10. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas.
Yoon LS; Catalano OA; Fritz S; Ferrone CR; Hahn PF; Sahani DV
J Comput Assist Tomogr; 2009; 33(3):363-8. PubMed ID: 19478628
[TBL] [Abstract][Full Text] [Related]
11. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas using MR findings and texture analysis.
Jeon SK; Kim JH; Yoo J; Kim JE; Park SJ; Han JK
Eur Radiol; 2021 May; 31(5):3394-3404. PubMed ID: 33140171
[TBL] [Abstract][Full Text] [Related]
12. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
13. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance cholangiopancreatography with compressed sensing at 1.5 T: clinical application for the evaluation of branch duct IPMN of the pancreas.
Henninger B; Steurer M; Plaikner M; Weiland E; Jaschke W; Kremser C
Eur Radiol; 2020 Nov; 30(11):6014-6021. PubMed ID: 32556465
[TBL] [Abstract][Full Text] [Related]
15. Evolution of incidental branch-duct intraductal papillary mucinous neoplasms of the pancreas: A study with magnetic resonance imaging cholangiopancreatography.
Girometti R; Pravisani R; Intini SG; Isola M; Cereser L; Risaliti A; Zuiani C
World J Gastroenterol; 2016 Nov; 22(43):9562-9570. PubMed ID: 27920477
[TBL] [Abstract][Full Text] [Related]
16. Agreement among Magnetic Resonance Imaging/Magnetic Resonance Cholangiopancreatography (MRI-MRCP) and Endoscopic Ultrasound (EUS) in the evaluation of morphological features of Branch Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN).
Uribarri-Gonzalez L; Keane MG; Pereira SP; Iglesias-García J; Dominguez-Muñoz JE; Lariño-Noia J
Pancreatology; 2018 Mar; 18(2):170-175. PubMed ID: 29338919
[TBL] [Abstract][Full Text] [Related]
17. Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance Imaging: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Seo N; Byun JH; Kim JH; Kim HJ; Lee SS; Song KB; Kim SC; Han DJ; Hong SM; Lee MG
Ann Surg; 2016 Mar; 263(3):557-64. PubMed ID: 25822687
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm.
Kawakami S; Fukasawa M; Shimizu T; Ichikawa S; Sato T; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Hayakawa H; Nakayama Y; Yamaguchi T; Inoue T; Maekawa S; Kawaida H; Motosugi U; Onishi H; Enomoto N
Medicine (Baltimore); 2019 Nov; 98(47):e18039. PubMed ID: 31764824
[TBL] [Abstract][Full Text] [Related]
19. Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.
Walter TC; Steffen IG; Stelter LH; Maurer MH; Bahra M; Faber W; Klein F; Bläker H; Hamm B; Denecke T; Grieser C
Eur Radiol; 2015 May; 25(5):1329-38. PubMed ID: 25433414
[TBL] [Abstract][Full Text] [Related]
20. Clinical Feasibility of Abbreviated Magnetic Resonance With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm.
Kang HJ; Lee DH; Lee JM; Yoo J; Weiland E; Kim E; Son Y
Invest Radiol; 2020 May; 55(5):262-269. PubMed ID: 32073419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
